PTD-Modified ATTEMPTS for Enhanced Toxin-Based Cancer Therapy: An in Vivo Proof-Of-Concept Study

Pharmaceutical Research- United States

doi 10.1007/s11095-015-1653-y

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study

Stem Cells International
Cell BiologyMolecular Biology
2013English

In Vivo Proof of Concept of Adoptive Immunotherapy for Hepatocellular Carcinoma Using Allogeneic Suicide Gene-Modified Killer Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Computer-Assisted Therapy for Medication-Resistant Auditory Hallucinations: Proof-Of-Concept Study

British Journal of Psychiatry
MedicinePsychiatryMental Health
2013English

A RNAi-based Therapeutic Proof of Concept Targets Salmonid Whirling Disease in Vivo

PLoS ONE
Multidisciplinary
2017English

Using Smart‐Messaging to Enhance Mindfulness‐Based Cognitive Therapy for Cancer Patients: A Mixed Methods Proof of Concept Evaluation

Psycho-Oncology
PsychiatryMental HealthOncologyExperimentalCognitive Psychology
2019English

Effects of Schema Group Therapy in Older Outpatients: A Proof of Concept Study

International Psychogeriatrics
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2014English

Recognition of Brain Metastases Using Gadolinium-Enhanced SWI MRI: Proof-Of-Concept Study

Frontiers in Neurology
Neurology
2020English

BCL-2 Antagonists: A Proof of Concept for CLL Therapy

Investigational New Drugs
OncologyPharmacology
2013English

Excision of HIV-1 DNA by Gene Editing: A Proof-Of-Concept in Vivo Study

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy